.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Federal Trade Commission
UBS
Fuji
Healthtrust
McKinsey
Deloitte
Cerilliant
Chubb
Harvard Business School

Generated: June 29, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087748

« Back to Dashboard
NDA 087748 describes BLEPHAMIDE S.O.P., which is a drug marketed by Allergan and is included in one NDA. It is available from two suppliers. Additional details are available on the BLEPHAMIDE S.O.P. profile page.

The generic ingredient in BLEPHAMIDE S.O.P. is prednisolone acetate; sulfacetamide sodium. There are eighty-five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the prednisolone acetate; sulfacetamide sodium profile page.

Summary for NDA: 087748

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 087748

Suppliers and Packaging for NDA: 087748

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BLEPHAMIDE S.O.P.
prednisolone acetate; sulfacetamide sodium
OINTMENT;OPHTHALMIC 087748 ANDA Allergan, Inc. 0023-0313 0023-0313-04 1 TUBE in 1 CARTON (0023-0313-04) > 3.5 g in 1 TUBE
BLEPHAMIDE S.O.P.
prednisolone acetate; sulfacetamide sodium
OINTMENT;OPHTHALMIC 087748 ANDA Physicians Total Care, Inc. 54868-1157 54868-1157-0 1 TUBE in 1 CARTON (54868-1157-0) > 3.5 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;OPHTHALMICStrength0.2%;10%
Approval Date:Dec 3, 1986TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Cerilliant
Teva
Boehringer Ingelheim
Federal Trade Commission
Julphar
Mallinckrodt
Healthtrust
Express Scripts
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot